IJ Pharmaceutical Research
Crossref
1. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®
- Morteza Jaffar-Aghaei
- Farzad Khanipour
- Amir Maghsoudi
- Rahim Sarvestani
- Mahdi Mohammadian
- Maryam Maleki
- Forugh Havasi
- Hossein Rahmani
- Amir-Hossein Karagah
- Mohammad-Reza Kazemali